酵素替代疗法市场规模 - 按酵素（Alglucosidase alfa、Agalsidase beta、Imiglucerase）、适应症（Gaucher、MPS、Pompe、SCID、Fabry）、给药途径、最终用户、2023-2032 年全球预测

由于生物製剂和各种遗传性疾病的标准治疗方法得到更广泛的接受，酵素替代疗法市场规模预计在 2023 年至 2032 年期间CAGR将超过 7%。

包括酵素替代疗法 (ERT) 在内的生物製剂作为戈谢病和法布瑞氏症等遗传性疾病的先进标靶治疗方法越来越受到重视。生物製剂的治疗功效和特异性以及随后在患者和医疗保健提供者中越来越多的采用也将促进市场成长。例如，2023年11月，武田的ADZYNMA获得美国FDA批准，成为第一个也是唯一一个用于治疗先天性血栓性血小板减少性紫斑症（cTTP）的重组ADAMTS13酶替代药物。

酵素替代疗法产业分为酵素类型、适应症、给药途径、最终使用者和地区。

就酵素类型而言，预计 2023 年至 2032 年伊米苷酶领域的市值CAGR将达到 8.4%。伊米苷酶已成为治疗戈谢氏症的有效酵素替代疗法。不断扩大的患者群体，加上对罕见疾病的认识和诊断不断提高，正在扩大对基于伊米苷酶的 ERT 的需求。此外，生物技术的不断进步和持续研究将有助于该领域的成长。

根据最终用户，输液中心领域的 ERT 产业到 2032 年可能会实现 7.5% 的CAGR。酵素缺乏症盛行率的上升，加上酵素替代疗法的接受度不断提高，将大大增加对输液中心服务的需求。此外，由于提供方便且受控的治疗环境，患者对输液中心的偏好不断增加，这可能会支持该细分市场的成长。

从地区来看，由于先进的医疗基础设施、意识的提高以及酵素缺乏症盛行率的上升，到 2032 年，欧洲酵素替代疗法市场规模预计将实现 6.8% 的CAGR。此外，欧洲製药公司和研究机构之间的合作将有助于促进 ERT 技术的进步。此外，越来越多的致力于透过创新疗法改善患者治疗结果将增强该地区的行业前景。例如，2023 年 5 月，欧盟委员会授予了 pegunigalsidase alfa 的营销授权，这是一种用于治疗法布瑞氏症的聚乙二醇 (PEG) 化酶。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：酵素替代疗法市场洞察

• 产业格局
• 产业影响力
  • 成长动力
    • 罕见遗传疾病的发生率不断增加
    • 对有效治疗方案的需求不断增长
    • 人们对罕见遗传疾病的认知不断增强
    • 生物技术与基因工程的进步
  • 产业陷阱与挑战
    • 治疗费用高
    • ERT 产品供应有限
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：酵素替代疗法市场估计与预测：按酵素类型，2018-2032

• 主要动向：依酵素类型
• 伊米苷酶
• 阿加糖酶β
• 塔利葡萄糖酶
• 维拉苷酶α
• 拉罗尼酶
• 阿葡萄糖苷酶α
• 半乳糖酶
• 艾杜磺酶
• 胰酶
• 聚乙二醇酶
• 其他酵素类型

第 6 章：酵素替代疗法市场估计与预测：按适应症分类，2018-2032 年

• 主要动向：依指示
• 戈谢氏症
• 法布瑞氏症
• 庞贝氏症
• 浆细胞疾病
• SCID
• 黏多醣贮积症（MPS）
  • MPS I - Hurler、Hurler Scheie 与 Scheie
  • MPS II - 猎人
  • MPS III - 圣菲利波
  • 其他黏多醣贮积症
• 其他适应症

第 7 章：酵素替代疗法市场估计与预测：按给药途径，2018-2032 年

• 主要动向：按给药途径
• 注射用
• 口服

第 8 章：酵素替代疗法市场估计与预测：按最终用户，2018-2032 年

• 主要动向：由最终用户
• 医院
• 点滴中心
• 其他最终用户

第 9 章：酵素替代疗法市场估计与预测：按地区，2018-2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 10 章：公司简介

• Sanofi
• Biomarin Pharmaceutical Inc.
• AbbVie Inc.
• Pfizer, Inc.
• Alexion Pharmaceuticals Inc.
• Allergan plc
• Horizon Pharma Public Limited Company
• Recordati Rare Diseases
• Protalix Biotherapeutics
• Amicus Therapeutics, Inc.

Enzyme Replacement Therapy Market size is set to exhibit over 7% CAGR from 2023 to 2032, driven by the broader acceptance of biologics and standard treatments for various genetic disorders.

Biologics, including enzyme replacement therapy (ERT) are gaining prominence as advanced and targeted treatments for genetic disorders, such as Gaucher disease and Fabry disease. The therapeutic efficacy and specificity of biologics and the subsequently rising adoption amongst patients and healthcare providers will also boost the market growth. For instance, in November 2023, Takeda's ADZYNMA received clearance from the U.S. FDA as the first and only recombinant ADAMTS13 enzyme replacement medication for the treatment of congenital thrombotic thrombocytopenic purpura (cTTP).

The enzyme replacement therapy industry is segmented into enzyme type, indication, route of administration, end-user, and region.

With respect to enzyme type, the market value from imiglucerase segment is anticipated to attain 8.4% CAGR from 2023-2032. Imiglucerase has emerged as an effective enzyme replacement therapy for the treatment of Gaucher disease. The expanding patient pool coupled with the rising awareness and diagnosis of rare diseases is amplifying the demand for Imiglucerase-based ERTs. Moreover, the rising advancements in biotechnology and continuous research will contribute to the segment growth.

Based on end-user, the ERT industry from the infusion centers segment is likely to record 7.5% CAGR through 2032. The rising prevalence of enzyme deficiency disorders coupled with the increasing acceptance of enzyme replacement therapies is adding significantly to the demand for infusion center services. Additionally, the increasing patient preference for infusion centers due to the availability of convenient and controlled environment for the treatment is likely to support the segment growth.

Regionally, the Europe enzyme replacement therapy market size is slated to observe 6.8% CAGR through 2032 driven advanced healthcare infrastructure, increasing awareness, and the rising prevalence of enzyme deficiency disorders. Moreover, collaborations between pharmaceutical companies and research institutions in Europe will contribute to increasing advancements in ERT technologies. Additionally, the growing commitment to improving patient outcomes through innovative therapies will augment the regional industry outlook. For instance, in May 2023, the European Commission granted marketing authorization for pegunigalsidase alfa, the Poly (ethylene glycol) (PEG) ylated enzyme for Fabry disease.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Enzyme replacement therapy 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Enzyme type trends
  • 2.1.4 Indication trends
  • 2.1.5 Route of Administration trends
  • 2.1.6 End-user trends

Chapter 3 Enzyme Replacement Therapy Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of rare genetic disorders
    • 3.2.1.2 Rising demand for effective treatment options
    • 3.2.1.3 Growing awareness of rare genetic diseases
    • 3.2.1.4 Advancements in biotechnology and genetic engineering
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of therapy
    • 3.2.2.2 Limited availability of ERT products
• 3.3 Growth potential analysis
  • 3.3.1 By enzyme type
  • 3.3.2 By indication
  • 3.3.3 By route of administration
  • 3.3.4 By end-user
  • 3.3.5 By region
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Technology landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic dashboard, 2022

Chapter 5 Enzyme Replacement Therapy Market Estimates and Forecast, By Enzyme Type, 2018-2032 (USD Million)

• 5.1 Key trends, by enzyme type
• 5.2 Imiglucerase
• 5.3 Agalsidase beta
• 5.4 Taliglucerase
• 5.5 Velaglucerase alfa
• 5.6 Laronidase
• 5.7 Alglucosidase alfa
• 5.8 Galsulfase
• 5.9 Idursulfase
• 5.10 Pancreatic enzymes
• 5.11 Pegademase
• 5.12 Other enzyme types

Chapter 6 Enzyme Replacement Therapy Market Estimates and Forecast, By Indication, 2018-2032 (USD Million)

• 6.1 Key trends, by indication
• 6.2 Gaucher disease
• 6.3 Fabry disease
• 6.4 Pompe disease
• 6.5 Plasma cell disorders
• 6.6 SCID
• 6.7 Mucopolysaccharidosis (MPS)
  • 6.7.1 MPS I - Hurler, Hurler Scheie and Scheie
  • 6.7.2 MPS II - Hunter
  • 6.7.3 MPS III - Sanfilippo
  • 6.7.4 Other mucopolysaccharidosis
• 6.8 Other indications

Chapter 7 Enzyme Replacement Therapy Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

• 7.1 Key trends, by route of administration
• 7.2 Parenteral
• 7.3 Oral

Chapter 8 Enzyme Replacement Therapy Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

• 8.1 Key trends, by end-user
• 8.2 Hospitals
• 8.3 Infusion centers
• 8.4 Other end-users

Chapter 9 Enzyme Replacement Therapy Market Estimates and Forecast, By Region, 2018-2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Sanofi
• 10.2 Biomarin Pharmaceutical Inc.
• 10.3 AbbVie Inc.
• 10.4 Pfizer, Inc.
• 10.5 Alexion Pharmaceuticals Inc.
• 10.6 Allergan plc
• 10.7 Horizon Pharma Public Limited Company
• 10.8 Recordati Rare Diseases
• 10.9 Protalix Biotherapeutics
• 10.10 Amicus Therapeutics, Inc.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by enzyme type (2022)
• TABLE 3 Market revenue, by indication (2022)
• TABLE 4 Market revenue, by route of administration (2022)
• TABLE 5 Market revenue, by end-user (2022)
• TABLE 6 Market share, by region (2022)
• TABLE 7 Global enzyme replacement therapy market size, by region, 2018 - 2022 (USD Million)
• TABLE 8 Global enzyme replacement therapy market size, by region, 2018 - 2022 (USD Million)
• TABLE 9 Global enzyme replacement therapy market size, by enzyme type, 2018 - 2022 (USD Million)
• TABLE 10 Global enzyme replacement therapy market size, by enzyme type, 2018 - 2022 (USD Million)
• TABLE 11 Global enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 12 Global enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 13 Global enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 14 Global enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 15 Global enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 16 Global enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 17 Industry impact forces
• TABLE 18 Imiglucerase market size, 2018-2022 (USD Million)
• TABLE 19 Imiglucerase market size, 2023-2032 (USD Million)
• TABLE 20 Agalsidase beta market size, 2018-2022 (USD Million)
• TABLE 21 Agalsidase beta market size, 2023-2032 (USD Million)
• TABLE 22 Taliglucerase market size, 2018-2022 (USD Million)
• TABLE 23 Taliglucerase market size, 2023-2032 (USD Million)
• TABLE 24 Velaglucerase alfa market size, 2018-2022 (USD Million)
• TABLE 25 Velaglucerase alfa market size, 2023-2032 (USD Million)
• TABLE 26 Laronidase market size, 2018-2022 (USD Million)
• TABLE 27 Laronidase market size, 2023-2032 (USD Million)
• TABLE 28 Alglucosidase alfa market size, 2018-2022 (USD Million)
• TABLE 29 Alglucosidase alfa market size, 2023-2032 (USD Million)
• TABLE 30 Galsulfase market size, 2018-2022 (USD Million)
• TABLE 31 Galsulfase market size, 2023-2032 (USD Million)
• TABLE 32 Idursulfase market size, 2018-2022 (USD Million)
• TABLE 33 Idursulfase market size, 2023-2032 (USD Million)
• TABLE 34 Pancreatic enzymes market size, 2018-2022 (USD Million)
• TABLE 35 Pancreatic enzymes market size, 2023-2032 (USD Million)
• TABLE 36 Pegademase market size, 2018-2022 (USD Million)
• TABLE 37 Pegademase market size, 2023-2032 (USD Million)
• TABLE 38 Other enzyme types market size, 2018-2022 (USD Million)
• TABLE 39 Other enzyme types market size, 2023-2032 (USD Million)
• TABLE 40 Gaucher disease market size, 2018-2022 (USD Million)
• TABLE 41 Gaucher disease market size, 2023-2032 (USD Million)
• TABLE 42 Fabry disease market size, 2018-2022 (USD Million)
• TABLE 43 Fabry disease market size, 2023-2032 (USD Million)
• TABLE 44 Pompe disease market size, 2018-2022 (USD Million)
• TABLE 45 Pompe disease market size, 2023-2032 (USD Million)
• TABLE 46 SCID market size, 2018-2022 (USD Million)
• TABLE 47 SCID market size, 2023-2032 (USD Million)
• TABLE 48 Mucopolysaccharidosis (MPS) market size, 2018-2022 (USD Million)
• TABLE 49 Mucopolysaccharidosis (MPS) market size, 2023-2032 (USD Million)
• TABLE 50 MPS I - Hurler, Hurler Scheie and Scheie market size, 2018-2022 (USD Million)
• TABLE 51 MPS I - Hurler, Hurler Scheie and Scheie market size, 2023-2032 (USD Million)
• TABLE 52 MPS II - Hunter market size, 2018-2022 (USD Million)
• TABLE 53 MPS II - Hunter market size, 2023-2032 (USD Million)
• TABLE 54 MPS III - Sanfilippo market size, 2018-2022 (USD Million)
• TABLE 55 MPS III - Sanfilippo market size, 2023-2032 (USD Million)
• TABLE 56 Other mucopolysaccharidosis market size, 2018-2022 (USD Million)
• TABLE 57 Other mucopolysaccharidosis market size, 2023-2032 (USD Million)
• TABLE 58 Other indications market size, 2018-2022 (USD Million)
• TABLE 59 Other indications market size, 2023-2032 (USD Million)
• TABLE 60 Parenteral market size, 2018-2022 (USD Million)
• TABLE 61 Parenteral market size, 2023-2032 (USD Million)
• TABLE 62 Oral market size, 2018-2022 (USD Million)
• TABLE 63 Oral market size, 2023-2032 (USD Million)
• TABLE 64 Hospitals market size, 2018-2022 (USD Million)
• TABLE 65 Hospitals market size, 2023-2032 (USD Million)
• TABLE 66 Infusion centers market size, 2018-2022 (USD Million)
• TABLE 67 Infusion centers market size, 2023-2032 (USD Million)
• TABLE 68 Other end-users market size, 2018-2022 (USD Million)
• TABLE 69 Other end-users market size, 2023-2032 (USD Million)
• TABLE 70 North America enzyme replacement therapy Market size, by country, 2018-2022 (USD Million)
• TABLE 71 North America enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
• TABLE 72 North America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 73 North America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 74 North America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 75 North America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 76 North America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 77 North America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 78 North America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 79 North America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 80 North America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 81 North America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 82 U.S. enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 83 U.S. enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 84 U.S. enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 85 U.S. enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 86 U.S. enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 87 U.S. enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 88 U.S. enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 89 U.S. enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 90 U.S. enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 91 U.S. enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 92 Canada enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 93 Canada enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 94 Canada enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 95 Canada enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 96 Canada enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 97 Canada enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 98 Canada enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 99 Canada enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 100 Canada enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 101 Canada enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 102 Europe enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
• TABLE 103 Europe enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
• TABLE 104 Europe enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 105 Europe enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 106 Europe enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 107 Europe enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 108 Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 109 Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 110 Europe enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 111 Europe enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 112 Europe enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 113 Europe enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 114 Germany enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 115 Germany enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 116 Germany enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 117 Germany enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 118 Germany enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 119 Germany enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 120 Germany enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 121 Germany enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 122 Germany enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 123 Germany enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 124 UK enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 125 UK enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 126 UK enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 127 UK enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 128 UK enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 129 UK enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 130 UK enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 131 UK enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 132 UK enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 133 UK enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 134 France enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 135 France enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 136 France enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 137 France enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 138 France enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 139 France enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 140 France enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 141 France enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 142 France enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 143 France enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 144 Spain enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 145 Spain enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 146 Spain enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 147 Spain enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 148 Spain enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 149 Spain enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 150 Spain enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 151 Spain enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 152 Spain enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 153 Spain enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 154 Italy enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 155 Italy enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 156 Italy enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 157 Italy enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 158 Italy enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 159 Italy enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 160 Italy enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 161 Italy enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 162 Italy enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 163 Italy enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 164 Rest of Europe enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 165 Rest of Europe enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 166 Rest of Europe enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 167 Rest of Europe enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 168 Rest of Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 169 Rest of Europe enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 170 Rest of Europe enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 171 Rest of Europe enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 172 Rest of Europe enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 173 Rest of Europe enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 174 Asia Pacific enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
• TABLE 175 Asia Pacific enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
• TABLE 176 Asia Pacific enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 177 Asia Pacific enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 178 Asia Pacific enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 179 Asia Pacific enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 180 Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 181 Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 182 Asia Pacific enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 183 Asia Pacific enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 184 Asia Pacific enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 185 Asia Pacific enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 186 Japan enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 187 Japan enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 188 Japan enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 189 Japan enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 190 Japan enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 191 Japan enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 192 Japan enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 193 Japan enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 194 Japan enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 195 Japan enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 196 China enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 197 China enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 198 China enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 199 China enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 200 China enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 201 China enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 202 China enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 203 China enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 204 China enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 205 China enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 206 India enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 207 India enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 208 India enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 209 India enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 210 India enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 211 India enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 212 India enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 213 India enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 214 India enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 215 India enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 216 Australia enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 217 Australia enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 218 Australia enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 219 Australia enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 220 Australia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 221 Australia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 222 Australia enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 223 Australia enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 224 Australia enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 225 Australia enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 226 South Korea enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 227 South Korea enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 228 South Korea enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 229 South Korea enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 230 South Korea enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 231 South Korea enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 232 South Korea enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 233 South Korea enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 234 South Korea enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 235 South Korea enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 236 Rest of Asia Pacific enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 237 Rest of Asia Pacific enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 238 Rest of Asia Pacific enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 239 Rest of Asia Pacific enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 240 Rest of Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 241 Rest of Asia Pacific enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 242 Rest of Asia Pacific enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 243 Rest of Asia Pacific enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 244 Rest of Asia Pacific enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 245 Rest of Asia Pacific enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 246 Latin America enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
• TABLE 247 Latin America enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
• TABLE 248 Latin America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 249 Latin America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 250 Latin America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 251 Latin America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 252 Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 253 Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 254 Latin America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 255 Latin America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 256 Latin America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 257 Latin America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 258 Brazil enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 259 Brazil enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 260 Brazil enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 261 Brazil enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 262 Brazil enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 263 Brazil enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 264 Brazil enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 265 Brazil enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 266 Brazil enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 267 Brazil enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 268 Mexico enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 269 Mexico enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 270 Mexico enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 271 Mexico enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 272 Mexico enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 273 Mexico enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 274 Mexico enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 275 Mexico enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 276 Mexico enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 277 Mexico enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 278 Rest of Latin America enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 279 Rest of Latin America enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 280 Rest of Latin America enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 281 Rest of Latin America enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 282 Rest of Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 283 Rest of Latin America enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 284 Rest of Latin America enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 285 Rest of Latin America enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 286 Rest of Latin America enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 287 Rest of Latin America enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 288 Middle East & Africa enzyme replacement therapy market size, by country, 2018-2022 (USD Million)
• TABLE 289 Middle East & Africa enzyme replacement therapy market size, by country, 2023-2032 (USD Million)
• TABLE 290 Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 291 Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 292 Middle East & Africa enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 293 Middle East & Africa enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 294 Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 295 Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 296 Middle East & Africa enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 297 Middle East & Africa enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 298 Middle East & Africa enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 299 Middle East & Africa enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 300 South Africa enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 301 South Africa enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 302 South Africa enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 303 South Africa enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 304 South Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 305 South Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 306 South Africa enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 307 South Africa enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 308 South Africa enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 309 South Africa enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 310 Saudi Arabia enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 311 Saudi Arabia enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 312 Saudi Arabia enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 313 Saudi Arabia enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 314 Saudi Arabia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 315 Saudi Arabia enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 316 Saudi Arabia enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 317 Saudi Arabia enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 318 Saudi Arabia enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 319 Saudi Arabia enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)
• TABLE 320 Rest of Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2018-2022 (USD Million)
• TABLE 321 Rest of Middle East & Africa enzyme replacement therapy market size, by enzyme type, 2023-2032 (USD Million)
• TABLE 322 Rest of Middle East & Africa enzyme replacement therapy market size, by indication, 2018-2022 (USD Million)
• TABLE 323 Rest of Middle East & Africa enzyme replacement therapy market size, by indication, 2023-2032 (USD Million)
• TABLE 324 Rest of Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2018-2022 (USD Million)
• TABLE 325 Rest of Middle East & Africa enzyme replacement therapy market size, by mucopolysaccharidosis (MPS), 2023-2032 (USD Million)
• TABLE 326 Rest of Middle East & Africa enzyme replacement therapy market size, by route of administration, 2018-2022 (USD Million)
• TABLE 327 Rest of Middle East & Africa enzyme replacement therapy market size, by route of administration, 2023-2032 (USD Million)
• TABLE 328 Rest of Middle East & Africa enzyme replacement therapy market size, by end-user, 2018-2022 (USD Million)
• TABLE 329 Rest of Middle East & Africa enzyme replacement therapy market size, by end-user, 2023-2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Enzyme replacement therapy market 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by enzyme type
• FIG 8 Growth potential analysis, by indication
• FIG 9 Growth potential analysis, by route of administration
• FIG 10 Growth potential analysis, by end-user
• FIG 11 Porter's analysis
• FIG 12 PESTEL analysis
• FIG 13 Company matrix analysis, 2022
• FIG 14 Global company market share analysis, 2022
• FIG 15 Competitive positioning matrix, 2022
• FIG 16 Strategic dashboard, 2022